Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael O Chaney

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|May 14, 2022
Mechanism of GAPDH Redox Signaling by H<sub>2</sub>O<sub>2</sub> Activation of a Two-Cysteine SwitchPaul A Hyslop, Michael O Chaney
International Journal of Molecular Sciences|March 29, 2023
Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative DiseasesPaul A Hyslop, Leonard N Boggs, Michael O Chaney
Chemical Biology & Drug Design|October 9, 2012
Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's diseaseKoteswara R Valasani, Gang Hu, Michael O Chaney, et al.
Journal of Chemical Information and Modeling|June 20, 2013
Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screeningKoteswara Rao Valasani, Michael O Chaney, Victor W Day, et al.
Neurological Research|September 25, 2003
A beta, aging, and Alzheimer's disease: a tale, models, and hypothesesMichael O Chaney, Jerome Baudry, Chera Esh, et al.
Biochimica Et Biophysica Acta|May 11, 2005
RAGE and amyloid beta interactions: atomic force microscopy and molecular modelingMichael O Chaney, W Blaine Stine, Tyler A Kokjohn, et al.
Bioorganic & Medicinal Chemistry|January 20, 2007
Azetidinones as vasopressin V1a antagonistsChristophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|May 14, 2022
Mechanism of GAPDH Redox Signaling by H<sub>2</sub>O<sub>2</sub> Activation of a Two-Cysteine SwitchPaul A Hyslop, Michael O Chaney
International Journal of Molecular Sciences|March 29, 2023
Origin of Elevated S-Glutathionylated GAPDH in Chronic Neurodegenerative DiseasesPaul A Hyslop, Leonard N Boggs, Michael O Chaney
Chemical Biology & Drug Design|October 9, 2012
Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's diseaseKoteswara R Valasani, Gang Hu, Michael O Chaney, et al.
Journal of Chemical Information and Modeling|June 20, 2013
Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screeningKoteswara Rao Valasani, Michael O Chaney, Victor W Day, et al.
Neurological Research|September 25, 2003
A beta, aging, and Alzheimer's disease: a tale, models, and hypothesesMichael O Chaney, Jerome Baudry, Chera Esh, et al.
Biochimica Et Biophysica Acta|May 11, 2005
RAGE and amyloid beta interactions: atomic force microscopy and molecular modelingMichael O Chaney, W Blaine Stine, Tyler A Kokjohn, et al.
Bioorganic & Medicinal Chemistry|January 20, 2007
Azetidinones as vasopressin V1a antagonistsChristophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Pageof 1